- CH₣2.57bn
- CH₣4.14bn
- CH₣3.92bn
Annual balance sheet for Clariant AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 427 | 718 | 593 | 395 | 617 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,049 | 1,065 | 964 | 1,030 | 913 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,211 | 2,619 | 2,217 | 2,128 | 2,230 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2,071 | 1,789 | 1,610 | 1,717 | 1,530 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 7,038 | 6,188 | 5,347 | 6,264 | 5,871 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,223 | 1,856 | 1,589 | 1,451 | 1,359 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 4,680 | 3,847 | 3,329 | 3,929 | 3,847 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 2,358 | 2,341 | 2,018 | 2,335 | 2,024 |
| Total Liabilities & Shareholders' Equity | 7,038 | 6,188 | 5,347 | 6,264 | 5,871 |
| Total Common Shares Outstanding |